Bioprospectum is a start-up in the area of technological innovation.The company concentrates on creating and developing biotechnological assets, from the bio prospecting of natural molecules and/or products of the biodiversity, through specialized scientific services, consultancies and proprietary technologies.
Its main focus is on the development of in silico and in vitro platforms for the identification of molecules with an emphasis on applications in the antioxidant, antimicrobial, anti-inflammatory and anti-cancer areas for the pharmaceutical, cosmetic and functional food industries. In doing this, it provides sustainable solutions for society through a network that interconnects the environment with computational and laboratory innovations.
Bioprospectum is a spin-off from i3S that brings together a multidisciplinary team of biochemists, biologists, chemists, physicists, physicians and biomedical scientists with extensive experience in their fields of research. In addition, it involves potential customers in specific projects. Currently, the company has a software prototype for the prospection of natural/semi-synthetic/synthetic molecules, biological extracts with high added value, and in vitro technologies that aim at revealing the antioxidant and anti-inflammatory potential of selected molecules for the development of new products. In addition, Bioprospectum has scientific and educational service platforms.